Jubilant Ingrevia Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Low debt relative to equity (D/E 0.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SOLARINDS Solar Industries India Limited | ₹18,830 | ₹1.7L Cr | 99.6 | 27.13 | 31.5 | 36.8 | 0.17 |
| PIDILITIND Pidilite Industries Limited | ₹1,609 | ₹1.6L Cr | 64.7 | 15.18 | 23.9 | 31 | 0.05 |
| SRF SRF Limited | ₹2,818 | ₹85K Cr | 44.8 | 5.95 | 14.3 | 14.6 | 0.35 |
| LINDEINDIA Linde India Limited | ₹7,004 +0.11% | ₹61K Cr | 111 | 15.49 | 13.6 | 18.2 | 0.02 |
| COROMANDEL Coromandel International Limited | ₹2,054 +1.68% | ₹60K Cr | 30.9 | 4.12 | 16.4 | 22 | 0.11 |
| FACT Fertilizers and Chemicals Travancore Limited | ₹833 +0.26% | ₹54K Cr | 3,642 | 41 | 1.61 | 8.65 | 2.79 |
| UPL UPL Limited | ₹607 | ₹52K Cr | 27.5 | 1.48 | 5.91 | 10.2 | 0.94 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
JUBLINGREA · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 51.47% | 51.47% | 51.47% | 51.47% | 51.47% | 51.47% |
| FII | 6.35% | 6.58% | 6.55% | 7.22% | 6.89% | 7.12% |
| DII | 11.17% | 13.60% | 14.07% | 15.47% | 15.99% | 15.91% |
| Public | 30.17% | 27.53% | 27.10% | 25.09% | 24.90% | 24.76% |
| Others | 0.82% | 0.81% | 0.81% | 0.77% | 0.74% | 0.73% |
Corporate Events
Dividend - Rs 2.50 Per Share
To consider and approve the financial results for the period ended Jun 30, 2026
Interim Dividend - Rs 2.50 Per Share
Dividend - Rs 2.50 Per Share
Interim Dividend - Rs 2.50 Per Share
Dividend - Rs 2.50 Per Share
Interim Dividend - Rs 2.50 Per Share
Dividend - Rs 2.50 Per Share
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.2K Cr ▲12.2% | ₹1.1K Cr ▼6.2% | ₹1.1K Cr ▲8.0% | ₹1.0K Cr ▼1.2% | ₹1.1K Cr ▼0.6% | ₹1.1K Cr ▲1.1% | ₹1.0K Cr ▲2.1% | ₹1.0K Cr |
| Op. Profit | ₹163 Cr ▲29.4% | ₹126 Cr ▼6.7% | ₹135 Cr ▼4.9% | ₹142 Cr ▼3.4% | ₹147 Cr ▲6.5% | ₹138 Cr ▲11.3% | ₹124 Cr ▲12.7% | ₹110 Cr |
| OPM | 14.0% ▲16.7% | 12.0% ▲0.0% | 12.0% ▼14.3% | 14.0% ▲0.0% | 14.0% ▲7.7% | 13.0% ▲8.3% | 12.0% ▲9.1% | 11.0% |
| Net Profit | ₹86 Cr ▲83.0% | ₹47 Cr ▼31.9% | ₹69 Cr ▼8.0% | ₹75 Cr ▲1.4% | ₹74 Cr ▲7.2% | ₹69 Cr ▲16.9% | ₹59 Cr ▲20.4% | ₹49 Cr |
| EPS (₹) | 5.43 ▲84.7% | 2.94 ▼32.6% | 4.36 ▼7.4% | 4.71 ▲1.3% | 4.65 ▲6.7% | 4.36 ▲17.8% | 3.7 ▲20.9% | 3.06 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹4.4K Cr ▲5.0% | ₹4.2K Cr ▲1.0% | ₹4.1K Cr ▼13.3% | ₹4.8K Cr ▼3.6% | ₹4.9K Cr ▲623.5% | ₹684 Cr | ₹0 Cr |
| Expenses | ₹3.8K Cr ▲4.5% | ₹3.7K Cr ▼1.3% | ₹3.7K Cr ▼12.2% | ₹4.2K Cr ▲2.8% | ₹4.1K Cr ▲624.5% | ₹567 Cr | ₹0 Cr |
| Op. Profit | ₹567 Cr ▲9.2% | ₹519 Cr ▲21.5% | ₹427 Cr ▼22.2% | ₹549 Cr ▼34.7% | ₹841 Cr ▲618.8% | ₹117 Cr | ₹0 Cr |
| OPM | 13.0% ▲8.3% | 12.0% ▲20.0% | 10.0% ▼9.1% | 11.0% ▼35.3% | 17.0% ▲0.0% | 17.0% | — |
| Other Income | ₹27 Cr ▼28.9% | ₹38 Cr ▲31.0% | ₹29 Cr ▼9.4% | ₹32 Cr ▲45.5% | ₹22 Cr ▲320.0% | ₹-10 Cr | ₹0 Cr |
| Interest | ₹49 Cr ▼12.5% | ₹56 Cr ▲5.7% | ₹53 Cr ▲140.9% | ₹22 Cr ▼29.0% | ₹31 Cr ▲342.9% | ₹7 Cr | ₹0 Cr |
| Depreciation | ₹175 Cr ▲10.8% | ₹158 Cr ▲16.2% | ₹136 Cr ▲11.5% | ₹122 Cr ▼0.8% | ₹123 Cr ▲459.1% | ₹22 Cr | ₹0 Cr |
| PBT | ₹370 Cr ▲7.6% | ₹344 Cr ▲28.4% | ₹268 Cr ▼38.7% | ₹437 Cr ▼38.4% | ₹709 Cr ▲820.8% | ₹77 Cr | ₹0 Cr |
| Tax % | 25.0% ▼7.4% | 27.0% ▼15.6% | 32.0% ▲6.7% | 30.0% ▼9.1% | 33.0% ▲10.0% | 30.0% | 0.0% |
| Net Profit | ₹278 Cr ▲10.8% | ₹251 Cr ▲37.2% | ₹183 Cr ▼40.6% | ₹308 Cr ▼35.4% | ₹477 Cr ▲783.3% | ₹54 Cr | ₹0 Cr |
| EPS (₹) | 17.45 ▲10.7% | 15.77 ▲37.4% | 11.48 ▼40.5% | 19.31 ▼35.5% | 29.93 ▲777.7% | 3.41 ▲200.3% | -3.4 |
| Div Payout | 14.0% ▼54.8% | 31.0% ▼27.9% | 43.0% ▲65.4% | 26.0% ▲52.9% | 17.0% ▲70.0% | 10.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Liabilities | |||||||
| Equity Capital | ₹16 Cr ▲0.0% | ₹16 Cr ▲0.0% | ₹16 Cr ▲0.0% | ₹16 Cr ▲0.0% | ₹16 Cr ▲0.0% | ₹16 Cr ▲31900.0% | ₹0.05 Cr |
| Reserves | ₹3.1K Cr ▲6.8% | ₹2.9K Cr ▲6.9% | ₹2.7K Cr ▲2.7% | ₹2.6K Cr ▲9.6% | ₹2.4K Cr ▲26.7% | ₹1.9K Cr | ₹0 Cr |
| Borrowings | ₹792 Cr ▲3.7% | ₹764 Cr ▲3.2% | ₹740 Cr ▲81.8% | ₹407 Cr ▲71.0% | ₹238 Cr ▼57.2% | ₹556 Cr | ₹0 Cr |
| Other Liabilities | ₹1.6K Cr ▲18.3% | ₹1.3K Cr ▲6.7% | ₹1.2K Cr ▲5.5% | ₹1.2K Cr ▲5.9% | ₹1.1K Cr ▲25.1% | ₹888 Cr | ₹0 Cr |
| Total Liabilities | ₹5.5K Cr ▲9.4% | ₹5.0K Cr ▲6.3% | ₹4.7K Cr ▲11.1% | ₹4.2K Cr ▲12.3% | ₹3.8K Cr ▲12.4% | ₹3.4K Cr | ₹0 Cr |
| Assets | |||||||
| Fixed Assets | ₹3.2K Cr ▲23.3% | ₹2.6K Cr ▲1.7% | ₹2.5K Cr ▲37.5% | ₹1.8K Cr ▲2.7% | ₹1.8K Cr ▼0.4% | ₹1.8K Cr | ₹0 Cr |
| CWIP | ₹154 Cr ▼70.7% | ₹525 Cr ▲58.6% | ₹331 Cr ▼37.0% | ₹525 Cr ▲201.7% | ₹174 Cr ▲167.7% | ₹65 Cr | ₹0 Cr |
| Investments | ₹33 Cr ▼10.8% | ₹37 Cr ▲146.7% | ₹15 Cr ▲87.5% | ₹8 Cr ▲33.3% | ₹6 Cr ▼88.0% | ₹50 Cr | ₹0 Cr |
| Other Assets | ₹2.1K Cr ▲12.9% | ₹1.9K Cr ▲2.1% | ₹1.8K Cr ▼1.9% | ₹1.9K Cr ▲3.7% | ₹1.8K Cr ▲24.8% | ₹1.4K Cr | ₹0 Cr |
| Total Assets | ₹5.5K Cr ▲9.4% | ₹5.0K Cr ▲6.3% | ₹4.7K Cr ▲11.1% | ₹4.2K Cr ▲12.3% | ₹3.8K Cr ▲12.4% | ₹3.4K Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹524 Cr ▲3.1% | ₹508 Cr ▲18.1% | ₹430 Cr ▼6.9% | ₹462 Cr ▲2.0% | ₹453 Cr ▲304.5% | ₹112 Cr | ₹0 Cr |
| Investing CF | ₹-276 Cr ▲29.0% | ₹-389 Cr ▲31.5% | ₹-568 Cr ▼21.1% | ₹-469 Cr ▼560.6% | ₹-71 Cr ▼315.2% | ₹33 Cr | ₹0 Cr |
| Financing CF | ₹-155 Cr ▼20.2% | ₹-129 Cr ▼189.6% | ₹144 Cr ▲242.9% | ₹42 Cr ▲110.0% | ₹-418 Cr ▼480.6% | ₹-72 Cr | ₹0 Cr |
| Net Cash Flow | ₹93 Cr ▲1133.3% | ₹-9 Cr ▼250.0% | ₹6 Cr ▼82.9% | ₹35 Cr ▲197.2% | ₹-36 Cr ▼149.3% | ₹73 Cr | ₹0 Cr |
| Free Cash Flow | ₹235 Cr ▲50.6% | ₹156 Cr ▲214.7% | ₹-136 Cr ▼750.0% | ₹-16 Cr ▼107.1% | ₹225 Cr ▲164.7% | ₹85 Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 65d ▲22.6% | 53d ▲6.0% | 50d ▲28.2% | 39d ▼9.3% | 43d ▼82.9% | 251d | — |
| Inventory Days | 140d ▼14.1% | 163d ▲1.9% | 160d ▲9.6% | 146d ▲24.8% | 117d ▼80.5% | 601d | — |
| Days Payable | 150d ▲6.4% | 141d ▲7.6% | 131d ▲15.9% | 113d ▲9.7% | 103d ▼85.0% | 685d | — |
| Cash Conv. Cycle | 55d ▼26.7% | 75d ▼6.3% | 80d ▲11.1% | 72d ▲26.3% | 57d ▼65.9% | 167d | — |
| Working Capital Days | 22d ▼24.1% | 29d ▼21.6% | 37d ▼11.9% | 42d ▼14.3% | 49d ▼77.7% | 220d | — |
| ROCE | 11.0% ▲0.0% | 11.0% ▲10.0% | 10.0% ▼37.5% | 16.0% ▼44.8% | 29.0% ▲262.5% | 8.0% | — |
Source: Screener.in · Lower days = better efficiency
About Jubilant Ingrevia Limited
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
Chemicals · Chemicals & Petrochemicals